Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Sorafenib For Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA)

Clinical Trial ID NCT03606590

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03606590

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial. JAMA 2015 4.00
2 NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer 2012 3.66
3 Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors. Proc Natl Acad Sci U S A 2007 2.64
4 Disruption of cancer cell replication by alternating electric fields. Cancer Res 2004 2.62
5 Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungs. Clin Exp Metastasis 2009 1.15
6 Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells. Sci Rep 2015 0.93
Next 100